Joseph J. Stephenson

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Daniel D. Von Hoff, Joseph J. Stephenson, Peter J. Rosen et al. · Journal of Clinical Oncology · 2010 · 643 citations

Medicine, Molecular Medicine, Oncology +17

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Michael B. Atkins, Sandra J. Lee, Bartosz Chmielowski et al. · Journal of Clinical Oncology · 2022 · 439 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer

James M. Burke, Donald L. Lamm, Maxwell V. Meng et al. · The Journal of Urology · 2012 · 235 citations

Medicine, Oncology, Pharmacology +17

Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors

Antoinette R. Tan, Darlene Gibbon, Mark N. Stein et al. · Cancer Chemotherapy and Pharmacology · 2013 · 106 citations

Pharmacy, Pharmacokinetics, Pharmacology +6

Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer

Bruce Montgomery, Mario A. Eisenberger, Matthew B. Rettig et al. · Clinical Cancer Research · 2015 · 79 citations

Medicine, Oncology, Pharmacology +17